YCBD
Cbdmd Inc
AMEX · Pharmaceuticals
$0.92
-0.02 (-2.21%)
Open$0.93
Previous Close$0.94
Day High$0.96
Day Low$0.87
52W High$29.51
52W Low$13.02
Volume—
Avg Volume507.5K
Market Cap9.86M
P/E Ratio20.34
EPS$1.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,925.2% upside
Current
$0.92
$0.92
Target
$27.92
$27.92
$15.39
$27.92 avg
$30.56
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.88M | 3.60M | 4.26M |
| Net Income | 504.3K | 438.1K | 574.3K |
| Profit Margin | 13.0% | 12.2% | 13.5% |
| EBITDA | 851.8K | 810.0K | 832.9K |
| Free Cash Flow | 419.4K | 302.1K | 332.0K |
| Rev Growth | +19.6% | +16.0% | +23.9% |
| Debt/Equity | 0.77 | 0.63 | 0.82 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |